Medicare Enrolled

Dr. Katherine Moretz, M.D.

Neurology with Special Qualifications in Child Neurology Physician · Savannah, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
6602 WATERS AVE, Savannah, GA 31406
9123547676
In practice since 2007 (19 years)
NPI: 1619191103 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moretz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moretz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moretz

Dr. Katherine Moretz is a neurology with special qualifications in child neurology physician in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Moretz performed 14,139 Medicare services across 286 unique beneficiaries.

Between the years covered by Open Payments, Dr. Moretz received a total of $137,659 from 83 pharmaceutical and/or device companies across 1050 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology with special qualifications in child neurology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moretz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in GA $137,659 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,139
Medicare services
Top 29% in GA for neurology with special qualifications in child neurology physician
286
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~744 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, eptinezumab-jjmr, 1 mg 13,800 $12 $52
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
82 $0 $10
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
81 $43 $210
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
69 $71 $475
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
54 $45 $250
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
38 $90 $600
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
15 $79 $1,250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
97.7% medium
0.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$137,659
Total received (2018-2024)
Avg $19,666/year across 7 years
Top 7% in GA for neurology with special qualifications in child neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,050
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125,014 (90.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,645 (9.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,936
2023
$25,844
2022
$29,406
2021
$22,175
2020
$12,904
2019
$39,905
2018
$1,488

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
JAZZ PHARMACEUTICALS INC.
$3,803
UCB, Inc.
$220
ABBVIE INC.
$189
Neurelis, Inc.
$180
Novartis Pharmaceuticals Corporation
$165
SK Life Science, Inc.
$135
Mallinckrodt Hospital Products Inc.
$134
CATALYST PHARMACEUTICALS, INC.
$92
Lundbeck LLC
$88
SCILEX PHARMACEUTICALS INC.
$85
Ipsen Biopharmaceuticals, Inc
$75
Eisai Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$69
ACADIA Pharmaceuticals Inc
$69
Alexion Pharmaceuticals, Inc.
$55
Sumitomo Pharma America, Inc.
$52
PFIZER INC.
$50
Neurocrine Biosciences, Inc.
$46
LivaNova USA, Inc.
$45
Biogen, Inc.
$43
Averitas Pharma Inc.
$40
CSL Behring
$34
Sandoz Inc.
$28
Celgene Corporation
$27
Grifols USA, LLC
$24
AQUESTIVE THERAPEUTICS, INC.
$23
ARGENX US, INC.
$18
Amgen Inc.
$17
Genentech USA, Inc.
$16
Marinus Pharmaceuticals, Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
InSightec,Inc
$14
Top 3 companies account for 70.9% of 2024 payments
All-time payments by company (2018-2024) ›
Greenwich Biosciences, Inc.
$70,074
JAZZ PHARMACEUTICALS INC.
$38,026
Neurelis, Inc.
$17,222
UCB, Inc.
$1,193
EMD Serono, Inc.
$1,039
Biogen, Inc.
$986
Sunovion Pharmaceuticals Inc.
$815
Novartis Pharmaceuticals Corporation
$589
Mallinckrodt Hospital Products Inc.
$584
Ipsen Biopharmaceuticals, Inc
$516
Lundbeck LLC
$503
SK Life Science, Inc.
$445
ABBVIE INC.
$413
Lilly USA, LLC
$410
CSL Behring
$282
Alexion Pharmaceuticals, Inc.
$206
Amgen Inc.
$199
Eisai Inc.
$189
Mallinckrodt LLC
$187
Sumitomo Pharma America, Inc.
$166
Allergan, Inc.
$160
Mallinckrodt Enterprises LLC
$158
Merz Pharmaceuticals, LLC
$150
LivaNova USA, Inc.
$135
Takeda Pharmaceuticals U.S.A., Inc.
$132
TG THERAPEUTICS, INC.
$128
ACADIA Pharmaceuticals Inc
$121
Genentech, Inc.
$120
Promius Pharma LLC
$108
Celgene Corporation
$104
Janssen Pharmaceuticals, Inc
$103
MITSUBISHI TANABE PHARMA AMERICA, INC.
$96
Biohaven Pharmaceutical Holding Company Ltd.
$96
CATALYST PHARMACEUTICALS, INC.
$92
AQUESTIVE THERAPEUTICS, INC.
$91
Genentech USA, Inc.
$91
Teva Pharmaceuticals USA, Inc.
$88
ARGENX US, INC.
$87
SCILEX PHARMACEUTICALS INC.
$85
EISAI INC.
$84
Neurocrine Biosciences, Inc.
$82
Harmony Biosciences LLC
$81
Mitsubishi Tanabe Pharma America, Inc.
$79
Biohaven Pharmaceuticals, Inc.
$75
Marinus Pharmaceuticals, Inc.
$57
Kyowa Kirin, Inc.
$56
PFIZER INC.
$50
Grifols USA, LLC
$49
HOSPIRA, INC.
$48
GENZYME CORPORATION
$46
Banner Life Sciences, LLC
$46
Avanir Pharmaceuticals, Inc.
$45
Upsher-Smith Laboratories LLC
$43
Horizon Therapeutics plc
$43
Averitas Pharma Inc.
$40
Sarepta Therapeutics, Inc.
$39
AveXis
$37
Scilex Pharmaceuticals Inc.
$37
Catalyst Pharmaceuticals, Inc.
$34
Sandoz Inc.
$28
Allergan Inc.
$27
Acorda Therapeutics, Inc
$27
HARMONY BIOSCIENCES LLC
$26
Azurity Pharmaceuticals, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$20
Merz North America, Inc.
$19
ANI Pharmaceuticals, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$17
AstraZeneca Pharmaceuticals LP
$15
Boston Scientific Corporation
$15
MERZ NORTH AMERICA, INC.
$15
E.R. Squibb & Sons, L.L.C.
$15
Bausch Health US, LLC
$14
IMPEL PHARMACEUTICALS INC.
$14
Alnylam Pharmaceuticals Inc.
$14
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$14
Saol Therapeutics Inc.
$14
InSightec,Inc
$14
Currax Pharmaceuticals LLC
$14
Medtronic, Inc.
$12
Neos Therapeutics, LP
$12
BOSTON SCIENTIFIC CORPORATION
$12
Retrophin, Inc.
$1
Top 3 companies account for 91.0% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADUHELM · AJOVY · APTIOM · AUSTEDO · AVONEX · Adzenys XR-ODT · Aimovig · BAFIERTAM · BOTOX · BRIUMVI · Briviact · CONTRAVE · DAYBUE · DUOPA · DYSPORT · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Eprontia · Evrysdi · Exablate · Exondys 51 · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INVEGA SUSTENNA · JZP-385 · KESIMPTA · KYNMOBI · LIBERVANT · LINQ II · LUMIZYME · Leqembi · MAVENCLAD · MIGRANAL · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONFI · ONPATTRO · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QUTENZA · RADICAVA · REXULTI · Radicava · Rebif · SOLIRIS · SPINRAZA · SYMPAZAN · Soliris · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIGADRONE (vigabatrin) for Oral Solution · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · Wakix · XCOPRI · XEOMIN · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOLGENSMA · ZTALMY · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology with special qualifications in child neurology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology with special qualifications in child neurology physician in GA.

Looking for a neurology with special qualifications in child neurology physician in Savannah?
Compare neurology with special qualifications in child neurology physicians in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse neurology with special qualifications in child neurology physicians nearby

Geographic Context

Neurology with special qualifications in child neurology physicians within 10 mi
3
Per 100K population
1.0
County median income
$69,575
Nearest hospital
COASTAL HARBOR TREATMENT CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Moretz is a mixed practice specialist, with above-average Medicare volume (top 29% in GA), with speaking/promotional industry engagement in the top 7% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Moretz experienced with injection, eptinezumab-jjmr, 1 mg?
Based on Medicare claims data, Dr. Moretz performed 13,800 injection, eptinezumab-jjmr, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moretz receive payments from pharmaceutical companies?
Yes. Dr. Moretz received a total of $137,659 from 83 companies across 1,050 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moretz's costs compare to other neurology with special qualifications in child neurology physicians in Savannah?
Dr. Moretz's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moretz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →